Inhibition of the cyclooxygenase pathway attenuates morphine-induced conditioned place preference in mice

Pharmacology Biochemistry and Behavior

Volumn 85, Issue 2, 2006, Pages 356-361

  Ghahremani, Mohammad Hossein ^a   Eghtesad, Elham ^a   Tahsili Fahadan, Pouya ^a,b   Sharifzadeh, Mohammad ^a   Amini, Mohsen ^a   Tootian, Zahra ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Celecoxib; Conditioned place preference; Cyclooxygenase pathway; Indomethacin; Mice; Morphine

Indexed keywords

CELECOXIB; DIMETHYL SULFOXIDE; INDOMETACIN; MORPHINE; PROSTAGLANDIN SYNTHASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG INHIBITION; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; CONDITIONING, OPERANT; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOMETHACIN; MALE; MICE; MORPHINE; PYRAZOLES; SULFONAMIDES;

EID: 33845308596     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.09.002     Document Type: Article

References (41)

1. Abbott F.V., and Hellemans K.G. Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects. Behav Brain Res 112 (2000) 177-186
2. Bhattacharjee A.K., Chang L., White L., Bazinet R.P., and Rapoport S.I. D-Amphetamine stimulates D(2) dopamine receptor-mediated brain signaling involving arachidonic acid in unanesthetized rats. J Cereb Blood Flow Metab (2006, March 1) [Electronic publication]
3. Bechara A., and van der Kooy D. Opposite motivational effects of endogenous opioids in brain and periphery. Nature 314 (1985) 533-534
4. Belzung C., and Barreau S. Differences in drug-induced place conditioning between BALB/c and C57B1/6 mice. Pharmacol Biochem Behav 65 (2000) 419-423
5. Breder C.D., Dewitt D., and Kraig R.P. Characterization of inducible cyclo-oxygenase in rat brain. J Comp Neurol 355 (1995) 296-315
6. De La Garza II R., Fabrizio K.R., Radoi G.E., Vlad T., and Asnis G.M. The non-steroidal anti-inflammatory drug diclofenac sodium attenuates lipopolysaccharide-induced alterations to reward behavior and corticosterone release. Behav Brain Res 149 (2004) 77-85
7. Fattore L., Melis M., Diana M., Fratta W., and Gessa G. The cyclo-oxygenase inhibitor nimesulide induces conditioned place preference in rats. Eur J Pharmacol 406 (2000) 75-77
8. Francischi J.N., Chaves C.T., Moura A.C., Lima A.S., Rocha O.A., Ferreira-Alves D.L., et al. Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br J Pharmacol 137 (2002) 837-844
9. Gonzalez S., Schmid P.C., Fernandez-Ruiz J., Krebsbach R., Schmid H.H., and Ramos J.A. Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats. Addict Biol 8 (2003) 159-166
10. Johnson M.A., Hill R.G., and Hughes J. A possible role for prostaglandins in the expression of morphine dependence in guinea-pig isolated ileum. Br J Pharmacol 93 (1988) 932-936
11. Kaufman W.E., Worley P.F., Pegg J., Bremer M., and Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci U S A 93 (1996) 2317-2321
12. Kawasaki M., Yoshihara Y., Yamaji M., and Watanabe B. Expression of prostaglandin endoperoxide synthase in rat brain. Mol Brain Res 19 (1993) 39-46
13. Langroudi R.M., Khoshnoodi M.A., Abadi N.Y.F., Fahadan P.T., Ghahremani M.H., and Dehpour A.R. Effect of cyclosporin A on morphine-induced place conditioning in mice: involvement of nitric oxide. Eur J Pharmacol 507 (2005) 107-115
14. Mackey W.B., and Van der Kooy D. Neuroleptics block the positive effects of amphetamine but not of morphine as measured by place conditioning. Pharmacol Biochem Behav 22 (1985) 101-105
15. Mayer L.A., and Parker L.A. Rewarding and aversive properties of IP and SC cocaine: assessment by place and taste conditioning. Psychopharmacology 112 (1993) 189-194
16. Melis M., Diana M., and Gessa G.L. COX-inhibitors increase morphine effects on mesolimbic dopamine neurons. Eur J Pharmacol 387 (2000) R1-R3
17. Morrow J.D., and Jackson Roberts L. Lipid-derived autacoids: eicosanoids and platelet activating factor. In: Hardman J.G., Limbird L.E., and Goodman Gillman A. (Eds). Goodman and Gillman's the pharmacological basis of therapeutics. International edition (2001), McGraw-Hill 669-687
18. Navidpour L., Shafaroodi H., Abdi K., Amini M., Ghahremani M.H., Dehpour A.R., et al. Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4H-1,2,4-triazoles as selective COX-2 inhibitors. Bioorg Med Chem 14 (2006) 2507-2517
19. Ono N., Abiru T., Sugiyama K., and Kamiya H. Influences of cyclo-oxygenase inhibitors on the cataleptic behavior induced by haloperidol in mice. Prostaglandins Leukot Essent Fat Acids 46 (1992) 59-63
20. Pinheiro R.M., and Calixto J.B. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm Res 51 (2002) 603-610
21. Pini L.A., Sandrini M., and Vitale G. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol 308 (1996) 31-40
22. Pini L.A., Vitale G., Ottani A., and Sandrini M. Naloxone-reversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther 280 (1997) 934-940
23. Powell K.J., Hosokawa A., Bell A., Sutak M., Milne B., Quirion R., et al. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br J Pharmacol 127 (1999) 631-644
24. Reid M.S., Ho L.B., Hsu K., Fox L., Tolliver B.K., Adams J.U., et al. Evidence for the involvement of cyclooxygenase activity in the development of cocaine sensitization. Pharmacol Biochem Behav 71 (2002) 37-54
25. Ross B.M., and Kish S.J. Lysophospholipid metabolising enzymes in human brain. J Neurochem 63 (1994) 1839-1848
26. Ross B.M., Brooks R., Lee M., Fletcher P.J., Kish S.J., and Turenne S. The effect of cyclo-oxygenase inhibition on indices of dopaminergic function. Abstr Soc Neurosci Meet 25 (1999) abs 385.3
27. Sahraei H., Ghazzaghi H., Zarrindast M.R., Ghoshooni H., Sepehri H., and Haeri-Rohan A. The role of alpha-adrenoceptor mechanism(s) in morphine-induced conditioned place preference in female mice. Pharmacol Biochem Behav 78 (2004) 135-141
28. Smith W.L., Borgeat P., and Fitzpatrick F.A. The eicosanoids: cyclooxygenase, lipoxygenase, and epoxygenase pathways. In: Vance D.E., and Vance J. (Eds). Biochemistry of lipids, lipoproteins and membranes (1992), Elsevier, Amsterdam 297-325
29. Suzuki T., Kishimoto Y., and Misawa M. Formalin- and carrageenan-induced inflammation attenuates place preferences produced by morphine, methamphetamine and cocaine. Life Sci 59 (1996) 1667-1674
30. Tahsili-Fahadan P., Yahyavi-Firouz-Abadi N., Khoshnoodi M.A., Motiei-Langroudi R., Tahaei S.A., Ghahremani M.H., et al. Agmatine potentiates morphine-induced conditioned place preference in mice: modulation by alpha(2)-adrenoceptors. Neuropsychopharmacology 31 (2006) 1722-1732
31. Teather L.A., Packard M.G., and Bazan N.G. Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation. Learn Mem 9 (2002) 41-47
32. Tocco G., Freire-Moar J., Schreiber S.S., Sakhim S.H., Aisen P.S., and Pasinetti G.M. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp Neurol 144 (1997) 339-349
33. Trang T., Sutak M., Quirion R., and Jhamandas K. The role of spinal neuropeptides and prostaglandins in opioid physical dependence. Br J Pharmacol 136 (2002) 37-48
34. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effect, recent progress and new issues. Prog Neurobiol 56 (1998) 613-672
35. Tzschentke T.M., and Schemidt W.J. Interaction of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and conditioning behavioral sensitization. Behav Brain Res 84 (1997) 99-107
36. Vaughan C.W., Ingram S.L., Connor M.A., and Christie M.J. How opioids inhibit GABA-mediated neurotransmission. Nature 390 (1997) 611-614
37. Williams J.T. The painless synergism of aspirin and opium. Nature 390 (1997) 557-559
38. Wise R.A. The role of reward pathways in the development of drug dependence. Pharmacol Ther 35 (1987) 227-263
39. Wise H. Neuronal prostacyclin receptors. Prog Drug Res 49 (1997) 123-154
40. Yamagata K., Andreasson K.I., Kaufman W.E., Barnes C.A., and Worley P.F. Expression of mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11 (1993) 371-386
41. Yamamoto T., Anggadiredja K., and Hiranita T. New perspectives in the studies on endocannabinoid and cannabis: a role for the endocannabinoid-arachidonic acid pathway in drug reward and long-lasting relapse to drug taking. J Pharmacol Sci 96 (2004) 382-388